{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:56:15Z","timestamp":1792090575704,"version":"4.4.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), comprises a spectrum of liver disorders characterized by excessive accumulation of triglycerides in hepatocytes. There are multiple treatment strategies proposed for pediatric MASLD, with lifestyle modifications and a balanced dietary regimen \u2013 particularly the Mediterranean diet in combination with weight loss, when needed \u2013 currently representing the cornerstone of clinical management. Behavioral psychological interventions are gaining increasing importance particularly in addressing comorbid eating disorders and supporting long-term adherence to therapeutic regimens. In addition, in daily clinical practice, the use of food supplements with antioxidant and hepatocyte anti-inflammatory effects is indicated in more advanced stages of steatosis, with the aim of limiting disease progression toward high-grade fibrosis and\/or cirrhosis. This review aims to summarize current behavioral and nutritional therapeutic approaches for the management of pediatric MASLD.<\/jats:p>","DOI":"10.3389\/fnut.2025.1667377","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:23:05Z","timestamp":1762964585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of non-pharmacological treatments in pediatric MASLD: a review of the literature"],"prefix":"10.3389","volume":"12","author":[{"given":"Antonella","family":"Mosca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Braghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pietrobattista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Alisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s42255-024-00985-1","article-title":"From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research","volume":"6","author":"Hsu","year":"2024","journal-title":"Nat Metab"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1316284","DOI":"10.3389\/fmed.2023.1316284","article-title":"MASLD treatment-a shift in the paradigm is imminent","volume":"10","author":"Machado","year":"2023","journal-title":"Front Med Lausanne"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jpn3.12402","article-title":"Pharmacological management of pediatric metabolic dysfunction-associated steatotic liver disease","volume":"80","author":"Abou Jaoudeh","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of Semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/oby.24184.2024","article-title":"Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE\u2122-1 and \u22122)","volume":"33","author":"Wharton","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","article-title":"Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD","volume":"82","author":"Barb","year":"2025","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(25)01073-6","article-title":"Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial","volume":"406","author":"Noureddin","year":"2025","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41569-020-00437-9","article-title":"Lifestyle interventions for the prevention and treatment of hypertension","volume":"18","author":"Valenzuela","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpeds.2022.07.004","article-title":"Clinically meaningful body mass index change impacts pediatric nonalcoholic fatty liver disease","volume":"250","author":"Khurana","year":"2022","journal-title":"J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.jfma.2022.01.011","article-title":"The effect of a multidisciplinary lifestyle modification program for obese and overweight children","volume":"121","author":"Chen","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061951","article-title":"Mediterranean diet as an antioxidant: the impact on metabolic health and overall wellbeing","volume":"13","author":"Gantenbein","year":"2021","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.3390\/jcm11123477","article-title":"Mediterranean diet: the beneficial effects of lycopene in non-alcoholic fatty liver disease","volume":"11","author":"Abenavoli","year":"2022","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/nu12092751","article-title":"\u03a9-3 and \u03c9-6 polyunsaturated fatty acids, obesity and Cancer","volume":"12","author":"D'Angelo","year":"2020","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"110551","DOI":"10.1016\/j.nut.2019.110551","article-title":"Dietary energy density and appetite: a systematic review and meta-analysis of clinical trials","volume":"69","author":"Moosavian","year":"2020","journal-title":"Nutrition"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1017\/S0007114521002270","article-title":"Effect of Mediterranean diet on liver enzymes: a systematic review and meta-analysis of randomised controlled trials","volume":"128","author":"Sangouni","year":"2022","journal-title":"Br J Nutr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1186\/s12889-024-19378-w","article-title":"Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis","volume":"24","author":"Jamil","year":"2024","journal-title":"BMC Public Health"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/09637486.2021.1979478","article-title":"The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial","volume":"73","author":"Akbulut","year":"2022","journal-title":"Int J Food Sci Nutr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.3390\/nu15224829","article-title":"Dietary and nutritional interventions in nonalcoholic fatty liver disease in Pediatrics","volume":"12","author":"Trobia","year":"2023","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2019.10532","article-title":"Effect of a low free sugar diet vs. usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial","volume":"322","author":"Schwimmer","year":"2019","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e13163","DOI":"10.1111\/ijpo.13163","article-title":"Effect of Indo-Mediterranean diet versus calorie-restricted diet in children with non-alcoholic fatty liver disease: a pilot randomized control trial","volume":"19","author":"Deshmukh","year":"2024","journal-title":"Pediatr Obes"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.30076","article-title":"Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial","volume":"68","author":"Properzi","year":"2018","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12887-021-02839-1","article-title":"Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD \u2013 an interventional pilot study","volume":"21","author":"Moran-Lev","year":"2021","journal-title":"BMC Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/chi.2013.0022","article-title":"A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children","volume":"9","author":"Ramon-Krauel","year":"2013","journal-title":"Child Obes"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/dc19-0351","article-title":"Effects of exercise in addition to a family-based lifestyle intervention program on hepatic fat in children with overweight","volume":"43","author":"Labayen","year":"2020","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1001281","DOI":"10.37349\/emed.2025.1001281","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management","volume":"6","author":"Adinolfi","year":"2025","journal-title":"Explor Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e2350680","DOI":"10.1001\/jamanetworkopen.2023.50680","article-title":"Occupational sitting time, leisure physical activity, and all-cause and cardiovascular disease mortality","volume":"7","author":"Gao","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"156028","DOI":"10.1016\/j.metabol.2024.156028","article-title":"The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus","volume":"161","author":"Zeng","year":"2024","journal-title":"Metabolism"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"Aasld practice guidance on the clinical assessment and management of non-alcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/apt.15063","article-title":"Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease","volume":"49","author":"Konerman","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.pcad.2018.01.013","article-title":"Evidence-based exercise recommendations to reduce hepatic fat content in youth-a systematic review and meta-analysis","volume":"103","author":"Medrano","year":"2018","journal-title":"J Clin Endocrinol Metabol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjms.2023.11.007","article-title":"Metabolic dysfunction associated steatotic liver disease: current practice, screening guidelines and management in the primary care setting","volume":"367","author":"Gupta","year":"2024","journal-title":"Am J Med Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/j.rgmx.2019.02.001","article-title":"Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: a scoping review","volume":"68","author":"Manna","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e13871","DOI":"10.1111\/obr.13871","article-title":"The impact of behavioral weight management interventions on eating behavior traits in adults with overweight or obesity: a systematic review and meta-analysis","volume":"26","author":"Kudlek","year":"2025","journal-title":"Obes Rev"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/17474124.2024.2385487","article-title":"Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease","volume":"18","author":"Righetti","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chc.2011.01.002","article-title":"Cognitive-behavioral therapy for weight management and eating disorders in children and adolescents","volume":"20","author":"Wilfley","year":"2011","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/NDT.S60735","article-title":"Social support networks and eating disorders: an integrative review of the literature","volume":"21","author":"Leonidas","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1745017901511010021","article-title":"Enhancing the emotional and social skills of the youth to promote their wellbeing and positive development: a systematic review of universal school-based randomized controlled trials","volume":"11","author":"Sancassiani","year":"2015","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cld.2017.08.002","article-title":"The genetics of pediatric nonalcoholic fatty liver disease","volume":"22","author":"Goyal","year":"2018","journal-title":"Clin Liver Dis"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2017.74","article-title":"NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD","volume":"14","author":"Mann","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/hep.28283","article-title":"Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: a multiethnic study","volume":"63","author":"Goffredo","year":"2016","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.18632\/aging.102293","article-title":"KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese","volume":"11","author":"Ji","year":"2019","journal-title":"Aging"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"goae029","DOI":"10.1093\/gastro\/goae029","article-title":"Advancements in pharmacological treatment of NAFLD\/MASLD: a focus on metabolic and liver-targeted interventions","volume":"12","author":"Ciardullo","year":"2024","journal-title":"Gastroenterol Rep"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1371\/journal.pone.0088005","article-title":"Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease","volume":"9","author":"Nobili","year":"2014","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1524830","DOI":"10.3389\/fnut.2025.1524830","article-title":"Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis","volume":"24","author":"Zhou","year":"2025","journal-title":"Front Nutr"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"101255","DOI":"10.1016\/j.plipres.2023.101255","article-title":"Omega-3 long-chain polyunsaturated fatty acids: metabolism and health implications","volume":"92","author":"Khan","year":"2023","journal-title":"Prog Lipid Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/ANNALS-24-02933","article-title":"Metabolic dysfunction-associated Steatotic liver disease","volume":"178","author":"Ali","year":"2025","journal-title":"Ann Intern Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1459790","DOI":"10.1155\/2016\/1459790","article-title":"Effects of Omega-3 fatty acid in nonalcoholic fatty liver disease: a Meta-analysis","volume":"2016","author":"Lu","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.3748\/wjg.14.6395","article-title":"Effetti degli acidi grassi polinsaturi n-3 degli oli di foca sulla steatosi epatica non alcolica associata a iperlipidemia","volume":"14","author":"Zhu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease","volume":"40","author":"Spadaro","year":"2008","journal-title":"Dig Liver Dis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jpeds.2015.01.056","article-title":"Omega-3 fatty acids therapy in children with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"166","author":"Janczyk","year":"2015","journal-title":"J Pediatr"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the north American Society for Pediatric Gastroenterology, hepatology, and nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00431-021-04262-1","article-title":"Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial","volume":"181","author":"El Amrousy","year":"2022","journal-title":"Eur J Pediatr"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial","volume":"96","author":"Nobili","year":"2011","journal-title":"Arch Dis Child"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jnutbio.2018.03.025","article-title":"Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids","volume":"58","author":"Spahis","year":"2018","journal-title":"J Nutr Biochem"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1139\/apnm-2016-0689","article-title":"Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial","volume":"42","author":"Z\u00f6hrer","year":"2017","journal-title":"Appl Physiol Nutr Metab"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e0168216","DOI":"10.1371\/journal.pone.0168216","article-title":"Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single Centre trial","volume":"11","author":"Della Corte","year":"2016","journal-title":"PLoS One"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.3390\/ijms25094901","article-title":"Vitamin D and metabolic dysfunction-associated steatotic liver disease (MASLD): novel mechanistic insights","volume":"25","author":"Aggeletopoulou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/ars.2018.7704","article-title":"The antioxidant effects of Hydroxytyrosol and vitamin E on pediatric nonalcoholic fatty liver disease, in a clinical trial: a new treatment?","volume":"31","author":"Nobili","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/hep.29043","article-title":"Treating nonalcoholic steatohepatitis in children: not a cinch task","volume":"65","author":"Alkhouri","year":"2017","journal-title":"Hepatology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update","volume":"12","author":"Barchetta","year":"2020","journal-title":"Nutrients"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.dld.2020.09.021","article-title":"Antioxidant activity of Hydroxytyrosol and vitamin E reduces systemic inflammation in children with paediatric NAFLD","volume":"53","author":"Mosca","year":"2021","journal-title":"Dig Liver Dis"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/nu17182932","article-title":"Exploring the role of extra virgin olive oil (EVOO) in MASLD: evidence from human consumption","volume":"17","author":"Bernardino","year":"2025","journal-title":"Nutrients"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/bit.27557","article-title":"Quercetin and hydroxytyrosol as modulators of hepatic steatosis: a NAFLD-on-a-chip study","volume":"118","author":"Gori","year":"2021","journal-title":"Biotechnol Bioeng"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3390\/nu14183791","article-title":"Combination treatment with Hydroxytyrosol and vitamin E improves NAFLD-related fibrosis","volume":"14","author":"Panera","year":"2022","journal-title":"Nutrients"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5009\/gnl240539","article-title":"Gut-liver axis: the role of intestinal microbiota and their metabolites in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"19","author":"Cui","year":"2025","journal-title":"Gut Liver"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3390\/ijms25116022","article-title":"Effects of probiotics on gut microbiota: an overview","volume":"25","author":"Chandrasekaran","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/MPG.0b013e31821f9b85","article-title":"Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease","volume":"52","author":"Vajro","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.clnu.2018.08.009","article-title":"Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Sabico","year":"2019","journal-title":"Clin Nutr"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41598-024-52482-w","article-title":"Vitamin E intake is inversely associated with NAFLD measured by liver ultrasound transient elastography","volume":"14","author":"Qi","year":"2024","journal-title":"Sci Rep"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.xcrm.2025.101939","article-title":"Chinese NAFLD clinical research network (CNAFLD CRN). Vitamin E (300 mg) in the treatment of MASH: a multi-center, randomized, double-blind, placebo-controlled study","volume":"6","author":"Song","year":"2025","journal-title":"Cell Rep Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/hep.22336","article-title":"Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12887-024-04993-8","article-title":"Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial","volume":"24","author":"Al-Baiaty","year":"2024","journal-title":"BMC Pediatr"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Nonalcoholic steatohepatitis clinical research network. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3945\/an.114.007955","article-title":"Choline, its potential role in nonalcoholic fatty liver disease, and the case for human and bacterial genes","volume":"7","author":"Sherriff","year":"2016","journal-title":"Adv Nutr"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s43016-025-01176-1","article-title":"High diversity of dietary flavonoid intake is associated with a lower risk of all-cause mortality and major chronic diseases","volume":"6","author":"Parmenter","year":"2025","journal-title":"Nat Food"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"109414","DOI":"10.1016\/j.jnutbio.2023.109414","article-title":"Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy","volume":"120","author":"Cao","year":"2023","journal-title":"J Nutr Biochem"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ajcnut.2024.07.013","article-title":"Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial","volume":"120","author":"Li","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/hep.27032","article-title":"How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations","volume":"60","author":"Dranoff","year":"2014","journal-title":"Hepatology"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"100254","DOI":"10.1016\/j.aohep.2020.08.071","article-title":"The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies","volume":"20","author":"Hayat","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.cgh.2021.09.042","article-title":"Coffee consumption is associated with lower liver stiffness: a nationally representative study","volume":"20","author":"Niezen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1186\/s12889-021-10991-7","article-title":"All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK biobank study","volume":"21","author":"Kennedy","year":"2021","journal-title":"BMC Public Health"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nutres.2022.07.010","article-title":"Coffee consumption has no effect on circulating markers of liver function but increases adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials","volume":"106","author":"Linden-Torres","year":"2022","journal-title":"Nutr Res"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12937-021-00694-5","article-title":"Effects of supplementation with main coffee components including caffeine and\/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Mansour","year":"2021","journal-title":"Nutr J"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/chi.2022.0032","article-title":"Effect of coffee and tea consumption on adolescent weight control: an interventional pilot study","volume":"19","author":"Moran-Lev","year":"2023","journal-title":"Child Obes"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/jhn.12172","article-title":"The suitability of caffeinated drinks for children: a systematic review of randomised controlled trials, observational studies and expert panel guidelines","volume":"27","author":"Ruxton","year":"2014","journal-title":"J Hum Nutr Diet"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1667377\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:23:06Z","timestamp":1762964586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1667377\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":92,"alternative-id":["10.3389\/fnut.2025.1667377"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1667377","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"article-number":"1667377"}}